查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601020

局部麻醉剂市场：按药物类型、类型、给药方法、分销管道、最终用途分类 - 全球预测 2025-2030

Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Type (Over-the-Counter, Prescription), Mode of Administration, Distribution Channel, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年局部麻醉剂市值为26.5亿美元，预计2024年将达28亿美元，复合年增长率为5.47%，预计到2030年将达到38.6亿美元。

局部麻醉剂对于麻醉身体的某些部位以防止手术、牙科手术和其他医疗干预期间的疼痛非常重要。这些药物会阻断神经传导并导致周围感觉丧失，但不会影响意识。局部麻醉在减少患者不适、促进小型手术、改善门诊病人手术并最终促进更有效的医疗服务方面的作用强调了局部麻醉的必要性。应用范围广泛，包括牙科、眼科、美容外科和整形外科，最终用户范围从医院和诊所到门诊手术中心和私人医生。

主要市场统计
基准年[2023] 26.5亿美元
预测年份 [2024] 28亿美元
预测年份 [2030] 38.6亿美元
复合年增长率（%） 5.47%

该市场的推动因素是慢性病增加和人口老化导致手术数量增加，需要低风险且有效的疼痛管理解决方案。技术进步，例如长效局部麻醉剂的开发，为满足对高效和长效镇痛不断增长的需求提供了潜在的机会。此外，开发减少全身副作用的局部药物输送系统的机会正在迅速增加，并引起了极大的关注。

然而，该市场面临严格的监管要求的挑战，这些要求可能会延迟产品核可，以及某些患者出现副作用或过敏反应的风险，这可能会限制广泛采用。此外，COVID-19 大流行扰乱了供应链，并使市场动态更加复杂。生物分解性麻醉剂和非注射给药方法等领域的创新可能会推动未来的成长。企业应投资研发副作用较少的药物，并与医疗机构合作，更了解其实际效果。市场竞争仍然激烈且充满活力，需要策略定价、遵守监管标准并保持适应性以实现永续成长。

市场动态：揭示快速发展的局部麻醉剂市场的关键市场洞察

供需的动态交互作用正在改变局部麻醉剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 随着全球手术数量的增加，用于治疗术后疼痛的局部麻醉剂的使用量增加
    • 扩大局部麻醉剂并提高核准率
  • 市场限制因素
    • 与局部麻醉剂产品召回相关的潜在风险
  • 市场机会
    • 整合奈米药物输送系统以实现有效的局部麻醉剂
    • 投资合成和非鸦片类局部麻醉剂的研发
  • 市场挑战
    • 局部麻醉剂的副作用

波特五力：驾驭局部麻醉剂市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解局部麻醉剂市场的外部影响

外部宏观环境因素局部麻醉剂市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解局部麻醉剂市场竞争状况

对局部麻醉剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵局部麻醉剂市场供应商的绩效评估

FPNV定位矩阵是评估局部麻醉剂市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划局部麻醉剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，局部麻醉剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的手术数量不断增加，用于治疗术后疼痛的局部麻醉剂的使用也在增加。
      • 扩大局部麻醉剂范围并提高核准率
    • 抑制因素
      • 与局部麻醉剂产品召回相关的潜在风险
    • 机会
      • 整合奈米药物输送系统以实现有效的局部麻醉剂
      • 投资合成和非鸦片类局部麻醉剂的研发
    • 任务
      • 局部麻醉剂的副作用
  • 市场区隔分析
    • 药物类型：提高Lidocaine功效、快速起效和应用多功能性的进展
    • 类型：使用处方笺局部麻醉剂进行中度和高度侵入性手术
    • 给药方式：注射麻醉剂对精准应用的新青睐
    • 分销管道：医院药房在确保医院内即时可靠地获得局部麻醉剂发挥关键作用。
    • 最终用途：在医院的各种外科手术中广泛使用局部麻醉剂
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依药物类型分類的局部麻醉剂市场

  • Bupivacaine
  • Chloroprocaine
  • Lidocaine
  • Mepivacaine/卡波卡因
  • Prilocaine
  • Ropivacaine

第七章局部麻醉剂市场：依类型

  • 在商店
  • 处方笺

第八章局部麻醉剂市场按管理方式

  • 可注射的
  • 表面麻醉

第九章局部麻醉剂市场：依通路分类

  • 药局/药房
  • 医院药房
  • 网路零售业

第 10 章局部麻醉剂市场：依最终用途分类

  • 门诊手术中心
  • 牙医诊所
  • 医院
  • 专科诊所

第十一章美洲局部麻醉剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太局部麻醉剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲局部麻醉剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 百特国际透过新型注射药物扩大美国药物组合
    • ZYNRELEF 的广泛应用增强了各种手术过程中的术后疼痛管理
    • Heron Therapeutics 与 CrossLink Life Sciences 结成策略联盟，加强 ZYNRELEF 的分销
    • Scilex控股公司旗舰产品ZTlido（Lidocaine局部系统）获得新专利
    • FDA核准Pasira 的 EXPAREL 的新申请，扩大非鸦片类疼痛治疗
    • 3M 将其牙科局部麻醉产品组合策略出售给 Pierrel SpA
    • 费森尤斯·卡比 (Fresenius Kabi) 宣布推出支持 RFID 的罗库溴铵注射液
    • Syntetica SA 扩大在美国的业务，在国内短缺的情况下推出盐酸Lidocaine注射液
    • 政府与 Kautron 研究所合作，在藻类局部麻醉剂生产上取得突破
  • 战略分析和建议
    • 阿斯彭医药控股有限公司
    • 百特国际有限公司
    • 帕西拉生物科技有限公司
    • Teva製药有限公司
    • 爱尔康有限公司

公司名单

  • AdvaCare Pharma
  • Alcon Inc.
  • Anesiva, Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Dentsply Sirona Inc.
  • Eisai Co., Ltd.
  • Endo International PLC
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Heron Therapeutics, Inc.
  • Hikma Pharmaceuticals PLC
  • ICPA Health Products Limited
  • Mahendra Chemicals
  • Merck KGaA
  • Niksan Pharmaceutical
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Pierrel SpA
  • Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
  • Septodont Holding
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wellona Pharma
Product Code: MRR-742BD5180AE5

The Local Anesthesia Drugs Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 3.86 billion by 2030.

Local anesthesia drugs are crucial in numbing specific areas of the body to prevent pain during surgical procedures, dental operations, and other medical interventions. These drugs block nerve conduction, leading to a loss of sensation in peripheral areas without affecting consciousness. The necessity of local anesthesia is underscored by its role in reducing patient discomfort, facilitating minor surgeries, and enhancing outpatient procedures, ultimately contributing to more efficient healthcare delivery. Its application spans across multiple domains including dentistry, ophthalmology, cosmetic surgery, and orthopedic processes, while end-users range from hospitals and clinics to ambulatory surgical centers and individual practitioners.

KEY MARKET STATISTICS
Base Year [2023] USD 2.65 billion
Estimated Year [2024] USD 2.80 billion
Forecast Year [2030] USD 3.86 billion
CAGR (%) 5.47%

The market is primarily driven by the increasing prevalence of surgeries due to rising chronic diseases and the growing elderly population, which necessitates low-risk, effective pain management solutions. Technological advancements, such as the development of long-acting local anesthetics, offer potential opportunities to cater to the growing demand for efficient and extended pain relief. Additionally, there's a burgeoning opportunity in developing localized drug delivery systems that reduce systemic side effects, thereby attracting significant attention.

However, the market faces challenges due to stringent regulatory requirements that can delay product approvals and the risk of side effects and allergic reactions in some patients, which can limit wider adoption. Moreover, the COVID-19 pandemic has disrupted supply chains, further complicating market dynamics. Innovating in areas such as biodegradable anesthetics and non-injection delivery methods may drive future growth. Companies should invest in R&D for drugs with fewer side effects and collaborate with medical institutions to better understand real-world efficacy. The market remains competitive and dynamic, requiring players to remain adaptive, ensuring strategic pricing and compliance with regulatory standards to capture sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Local Anesthesia Drugs Market

The Local Anesthesia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
    • Increase in expansion and approval rate of local anesthesia drugs
  • Market Restraints
    • Potential risk associated with the product recall of local anesthetic drugs
  • Market Opportunities
    • Integration of nano-based drug delivery systems for effective local anesthetics
    • Investment in R&D for synthetic and non-opioid local anesthetics
  • Market Challenges
    • Side effects of local anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Local Anesthesia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Local Anesthesia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Local Anesthesia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Local Anesthesia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Local Anesthesia Drugs Market

A detailed market share analysis in the Local Anesthesia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Local Anesthesia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Local Anesthesia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Local Anesthesia Drugs Market

A strategic analysis of the Local Anesthesia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Local Anesthesia Drugs Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Alcon Inc., Anesiva, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Boehringer Ingelheim International GmbH, Dentsply Sirona Inc., Eisai Co., Ltd., Endo International PLC, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Heron Therapeutics, Inc., Hikma Pharmaceuticals PLC, ICPA Health Products Limited, Mahendra Chemicals, Merck KGaA, Niksan Pharmaceutical, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Pierrel S.p.A., Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd., Septodont Holding, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Wellona Pharma.

Market Segmentation & Coverage

This research report categorizes the Local Anesthesia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Bupivacaine, Chloroprocaine, Lidocaine, Mepivacaine/ Carbocaine, Prilocaine, and Ropivacaine.
  • Based on Type, market is studied across Over-the-Counter and Prescription.
  • Based on Mode of Administration, market is studied across Injectable and Surface Anesthetic.
  • Based on Distribution Channel, market is studied across Drug Stores/Pharmacies, Hospitals Pharmacies, and Online Retailing.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Dental Clinics, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
      • 5.1.1.2. Increase in expansion and approval rate of local anesthesia drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk associated with the product recall of local anesthetic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of nano-based drug delivery systems for effective local anesthetics
      • 5.1.3.2. Investment in R&D for synthetic and non-opioid local anesthetics
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects of local anesthetic drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Advancements to improve the effectiveness, rapid onset, and versatility in the application of lidocaine
    • 5.2.2. Type: Usage of prescription local anesthesia drugs for moderately and highly invasive surgeries
    • 5.2.3. Mode of Administration: Emerging preference for injectable anesthetics in precise applications
    • 5.2.4. Distribution Channel: Critical role played by hospital pharmacies for ensuring immediate and reliable access to local anesthesia drugs in hospital settings
    • 5.2.5. End-Use: Extensive utilization of local anesthesia drugs in hospital settings for diverse surgical operations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Local Anesthesia Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Bupivacaine
  • 6.3. Chloroprocaine
  • 6.4. Lidocaine
  • 6.5. Mepivacaine/ Carbocaine
  • 6.6. Prilocaine
  • 6.7. Ropivacaine

7. Local Anesthesia Drugs Market, by Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter
  • 7.3. Prescription

8. Local Anesthesia Drugs Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Surface Anesthetic

9. Local Anesthesia Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Drug Stores/Pharmacies
  • 9.3. Hospitals Pharmacies
  • 9.4. Online Retailing

10. Local Anesthesia Drugs Market, by End-Use

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Dental Clinics
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Americas Local Anesthesia Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Local Anesthesia Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Local Anesthesia Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Baxter International Inc. Expands the U.S. Pharmaceuticals Portfolio with New Injectable Products
    • 14.3.2. Broadened Applications of ZYNRELEF Enhance Postoperative Pain Management in Diverse Surgical Procedures
    • 14.3.3. Strategic Alliance between Heron Therapeutics and CrossLink Life Sciences to Enhance Distribution of ZYNRELEF
    • 14.3.4. New Patent Issuence for Scilex Holding Company for Its Lead Commercial Product ZTlido (lidocaine topical system)
    • 14.3.5. FDA Approves New Applications for Pacira's EXPAREL Expanding Non-Opioid Pain Management
    • 14.3.6. Strategic Divestiture of Dental Local Anesthetic Portfolio by 3M to Pierrel S.p.A.
    • 14.3.7. Fresenius Kabi Introduces RFID-Enabled Rocuronium Bromide Injection
    • 14.3.8. Sintetica S.A. Expands U.S. Presence with Launch of Lidocaine Hydrochloride Injection Amid National Shortage
    • 14.3.9. Breakthrough in Algae-Based Local Anaesthetic Production through Government-Cawthron Institute Partnership
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Aspen Pharmacare Holdings Limited
    • 14.4.2. Baxter International, Inc.
    • 14.4.3. Pacira BioSciences, Inc.
    • 14.4.4. Teva Pharmaceutical Industries Ltd.
    • 14.4.5. Alcon Inc.

Companies Mentioned

  • 1. AdvaCare Pharma
  • 2. Alcon Inc.
  • 3. Anesiva, Inc.
  • 4. Aspen Pharmacare Holdings Limited
  • 5. AstraZeneca PLC
  • 6. B. Braun SE
  • 7. Baxter International, Inc.
  • 8. Boehringer Ingelheim International GmbH
  • 9. Dentsply Sirona Inc.
  • 10. Eisai Co., Ltd.
  • 11. Endo International PLC
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Fresenius SE & Co. KGaA
  • 14. Heron Therapeutics, Inc.
  • 15. Hikma Pharmaceuticals PLC
  • 16. ICPA Health Products Limited
  • 17. Mahendra Chemicals
  • 18. Merck KGaA
  • 19. Niksan Pharmaceutical
  • 20. Novartis AG
  • 21. Pacira BioSciences, Inc.
  • 22. Pfizer Inc.
  • 23. Pierrel S.p.A.
  • 24. Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
  • 25. Septodont Holding
  • 26. Teva Pharmaceutical Industries Ltd.
  • 27. Viatris Inc.
  • 28. Wellona Pharma

LIST OF FIGURES

  • FIGURE 1. LOCAL ANESTHESIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. LOCAL ANESTHESIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LOCAL ANESTHESIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHLOROPROCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE/ CARBOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURFACE ANESTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG STORES/PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE RETAILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023